The mechanism: RTX's Raytheon segment sits at the intersection of two policy pipes that have nothing to do with each other except that both terminate in the same missile plants. Pipe one is the Pentagon's urgent restocking of munitions expended or forward-deployed during the Israel-Iran conflict and Red Sea/Houthi operations — interceptors and strike weapons that get replaced dollar-for-dollar (often at a premium) through supplemental and base-budget procurement. Pipe two is NATO's Hague Summit Declaration, where 31 allies committed to a 5% of GDP defense-investment floor by 2035 (3.5% core military, 1.5% resilience), a multi-year budget mandate written into national law and procurement roadmaps regardless of whether a shot is ever fired. One is a war-consumption reflex; the other is a treaty-driven spending floor. Both route through Raytheon's order book, which is why the stock can rip on a Tehran headline and rip again on a Brussels budget vote — for entirely different reasons.
Who cashes in:
- RTX — Raytheon just signed five Department of War production-framework agreements lifting annual output to 1,000+ Tomahawks, 1,900+ AMRAAMs, and 500+ SM-6s; separately, NATO members (Netherlands alone placed a $600M+ Patriot order in Q1) are locking in multi-year Patriot/GEM-T buys under Hague-mandated budgets. Two demand curves, one backlog, now near $74 billion in the Raytheon segment alone.
- LMT — PAC-3 interceptors (the Patriot's actual missile) and THAAD draw down in the same Middle East air-defense fights, while NATO members' Hague roadmaps name Patriot batteries explicitly as capability-target line items.
- NOC — Precision munitions and solid rocket motor capacity (feeding both Raytheon and Lockheed) benefit from Pentagon urgency funding regardless of which prime's missile body gets filled.
- GD — Artillery and combat vehicle lines tied to European stockpile replenishment sit squarely inside the "3.5% core military" bucket of Hague allocations.